The study of Abdelaziz et al. (2018) showed a marked decline in MDA level and relative increase in GSH and SOD when Flavo (20 mg/kg) for 16 days was used in an ovalbumin-induced mouse asthma model. This evidence concerns the gene SOD1 and asthma.